APA

Gati A., Guerra N., Gaudin C., Da Rocha S., Escudier B., Lécluse Y., Bettaieb A., Chouaib S. & Caignard A. (20040116). CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling. : Cancer research.

Chicago

Gati Asma, Guerra Nadia, Gaudin Catherine, Da Rocha Sylvie, Escudier Bernard, Lécluse Yann, Bettaieb Ali, Chouaib Salem and Caignard Anne. 20040116. CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling. : Cancer research.

Harvard

Gati A., Guerra N., Gaudin C., Da Rocha S., Escudier B., Lécluse Y., Bettaieb A., Chouaib S. and Caignard A. (20040116). CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling. : Cancer research.

MLA

Gati Asma, Guerra Nadia, Gaudin Catherine, Da Rocha Sylvie, Escudier Bernard, Lécluse Yann, Bettaieb Ali, Chouaib Salem and Caignard Anne. CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling. : Cancer research. 20040116.